{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1146.1635",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2022-01-18T01:02:48.000-05:00",
    "profile" : ["http://hl7.org/fhir/StructureDefinition/shareablevalueset",
    "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]
  },
  "extension" : [{
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString" : "CSTE Author"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-keyWord",
    "valueString" : "Hepatitis_C,Trigger"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate" : "2022-12-15"
  },
  {
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate" : "2022-01-18"
  }],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1635",
  "identifier" : [{
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1146.1635"
  }],
  "version" : "20220118",
  "name" : "SofosbuvirVelpatasvirVoxilaprevirCombinationRXNORM",
  "title" : "Sofosbuvir Velpatasvir Voxilaprevir Combination (RXNORM)",
  "status" : "active",
  "experimental" : false,
  "date" : "2022-01-18T01:02:48-05:00",
  "publisher" : "CSTE Steward",
  "description" : "All prescribable medication formulations represented using either a \"generic\" or \"brand-specific\" concept. This includes RxNorm codes whose Term Type is SCD (semantic clinical drug), or SBD (semantic brand drug). GPCK (generic pack), BPCK (brand pack), SCDG (semantic clinical drug group), SBDG (semantic brand drug group), SCDF (semantic clinical drug form), IN (ingredient) or SBDF (semantic brand drug form) are NOT included in this value set.",
  "jurisdiction" : [{
    "extension" : [{
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
      "valueString" : "UNKNOWN"
    }]
  }],
  "purpose" : "(Clinical Focus: This set of values contains codes for prescribable medications with Sofosbuvir Velpatasvir  Voxilaprevir Combination),(Data Element Scope: Medications that were administered, ordered or prescribed.),(Inclusion Criteria: Sofosbuvir Velpatasvir  Voxilaprevir Combination),(Exclusion Criteria: SBDG (semantic brand drug group), SCDF (semantic clinical drug form), or SBDF (semantic brand drug form).)",
  "compose" : {
    "include" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "concept" : [{
        "code" : "1939329",
        "display" : "sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet"
      },
      {
        "code" : "1939335",
        "display" : "sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet [Vosevi]"
      }]
    }]
  },
  "expansion" : {
    "identifier" : "urn:uuid:0d1cbbe8-576a-4eae-8686-4c53bb7b7d8a",
    "timestamp" : "2023-09-26T13:15:52-04:00",
    "total" : 2,
    "offset" : 0,
    "parameter" : [{
      "name" : "count",
      "valueInteger" : 1000
    },
    {
      "name" : "offset",
      "valueInteger" : 0
    }],
    "contains" : [{
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1939329",
      "display" : "sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet"
    },
    {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "version" : "09052023",
      "code" : "1939335",
      "display" : "sofosbuvir 400 MG / velpatasvir 100 MG / voxilaprevir 100 MG Oral Tablet [Vosevi]"
    }]
  }
}